Vitreoretinal disease (e.g., vitreous hemorrhage, macular hole, epiretinal membrane, retinal detachment, or diabetic retinopathy) and concomitant cataract
Conditions
Interventions
Posterior Capsulotomy Group:NA
Non-Posterior Capsulotomy Group:NA
Sponsors
Tianjin Medical University Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age >=18 years. 2. Patients diagnosed with a vitreoretinal disease (e.g., vitreous hemorrhage, macular hole, epiretinal membrane, retinal detachment, or diabetic retinopathy) and concomitant cataract who qualified for combined phaco-vitrectomy surgery. 3. No prior ocular surgery.
Exclusion criteria
Exclusion criteria: 1. Previous intraocular surgery (including cataract surgery); 2. Uncontrolled glaucoma (IOP =25 mmHg on medication); 3. Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Anterior Chamber Depth at 1 Month Postoperatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anterior Chamber Depth at 1 Month Postoperatively;Tilt and Decentration of the Intraocular Lens (IOL) at 1 Month Postoperatively;Best Corrected Visual Acuity (BCVA) at 1 Month Postoperatively.; | — |
Countries
China
Contacts
Public ContactHan Jindong
Tianjin Medical University Eye Hospital
Outcome results
None listed